{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T11:03:46Z","timestamp":1793703826756,"version":"4.5.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI19\/00449"],"award-info":[{"award-number":["PI19\/00449"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI23\/00173"],"award-info":[{"award-number":["PI23\/00173"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FI20\/00076"],"award-info":[{"award-number":["FI20\/00076"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["JR22\/00014"],"award-info":[{"award-number":["JR22\/00014"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Joan Rod\u00e9s\u2013Josep Baselga Fundaci\u00f3n BBVA"},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["AACSF_21_723056"],"award-info":[{"award-number":["AACSF_21_723056"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fundaci\u00f3 Rosa Maria Vivar"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s00415-025-13556-5","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T03:28:39Z","timestamp":1765942119000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Plasma p-Tau217 and GFAP predict widespread cognitive decline in Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"273","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1341-9834","authenticated-orcid":false,"given":"N\u00faria","family":"Guill\u00e9n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Esteller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Sarto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iria","family":"Perales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"R\u00edos-Guillermo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miquel","family":"Massons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Mart\u00edn-Sobrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep Maria","family":"Aug\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Naranjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Ruiz-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Junc\u00e0-Parella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Rigol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Patricio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri\u00e0","family":"Tort-Merino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guadalupe","family":"Fernandez-Villullas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desir\u00e9e","family":"Alcon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aina","family":"Comas-Albert\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Antonell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergi","family":"Borrego-\u00c9cija","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Castellv\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"S\u00e1nchez-Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mircea","family":"Balasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neus","family":"Falg\u00e0s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5066-4150","authenticated-orcid":false,"given":"Albert","family":"Llad\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"key":"13556_CR1","volume-title":"World Alzheimer report 2021: journey through the diagnosis of dementia","author":"Alzheimer\u2019s Disease International","year":"2021","unstructured":"Alzheimer\u2019s Disease International (2021) World Alzheimer report 2021: journey through the diagnosis of dementia. Alzheimer\u2019s Disease International, London"},{"key":"13556_CR2","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K et al (2018) NIA\u2010AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement 14:535\u2013562. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.018","journal-title":"Alzheimers Dement"},{"key":"13556_CR3","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","volume":"26","author":"H Hampel","year":"2021","unstructured":"Hampel H, Hardy J, Blennow K et al (2021) The amyloid-\u03b2 pathway in Alzheimer\u2019s disease. Mol Psychiatry 26:5481\u20135503. https:\/\/doi.org\/10.1038\/s41380-021-01249-0","journal-title":"Mol Psychiatry"},{"key":"13556_CR4","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13195-017-0283-5","volume":"9","author":"PS Aisen","year":"2017","unstructured":"Aisen PS, Cummings J, Jack CR et al (2017) On the path to 2025: understanding the Alzheimer\u2019s disease continuum. Alzheimers Res Ther 9:60. https:\/\/doi.org\/10.1186\/s13195-017-0283-5","journal-title":"Alzheimers Res Ther"},{"key":"13556_CR5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jalz.2007.10.018","volume":"4","author":"F Cortes","year":"2008","unstructured":"Cortes F, Nourhash\u00e9mi F, Gu\u00e9rin O et al (2008) Prognosis of Alzheimer\u2019s disease today: a two-year prospective study in 686 patients from the REAL-FR Study. Alzheimer Dement 4:22\u201329. https:\/\/doi.org\/10.1016\/j.jalz.2007.10.018","journal-title":"Alzheimer Dement"},{"key":"13556_CR6","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1017\/S1041610213000653","volume":"25","author":"I Hallikainen","year":"2013","unstructured":"Hallikainen I, H\u00e4nninen T, Fraunberg M et al (2013) Progression of Alzheimer\u2019s disease during a three-year follow-up using the CERAD-NB total score: Kuopio ALSOVA study. Int Psychogeriatr 25:1335\u20131344. https:\/\/doi.org\/10.1017\/S1041610213000653","journal-title":"Int Psychogeriatr"},{"key":"13556_CR7","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.3233\/JAD-170436","volume":"61","author":"RS Eldholm","year":"2018","unstructured":"Eldholm RS, Barca ML, Persson K et al (2018) Progression of Alzheimer\u2019s disease: a longitudinal study in Norwegian memory clinics. J Alzheimers Dis 61:1221\u20131232. https:\/\/doi.org\/10.3233\/JAD-170436","journal-title":"J Alzheimers Dis"},{"key":"13556_CR8","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/WAD.0000000000000124","volume":"30","author":"M Canevelli","year":"2016","unstructured":"Canevelli M, Kelaiditi E, del Campo N et al (2016) Predicting the rate of cognitive decline in Alzheimer disease: data from the ICTUS Study. Alzheimer Dis Assoc Disord 30:237\u2013242. https:\/\/doi.org\/10.1097\/WAD.0000000000000124","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"13556_CR9","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1002\/acn3.51689","volume":"9","author":"A Tort-Merino","year":"2022","unstructured":"Tort-Merino A, Falg\u00e0s N, Allen IE et al (2022) Early-onset Alzheimer\u2019s disease shows a distinct neuropsychological profile and more aggressive trajectories of cognitive decline than late-onset. Ann Clin Transl Neurol 9:1962\u20131973. https:\/\/doi.org\/10.1002\/acn3.51689","journal-title":"Ann Clin Transl Neurol"},{"key":"13556_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-024-01478-9","volume":"16","author":"AJ Mendes","year":"2024","unstructured":"Mendes AJ, Ribaldi F, Lathuili\u00e8re A et al (2024) Comparison of plasma and neuroimaging biomarkers to predict cognitive decline in non-demented memory clinic patients. Alzheimers Res Ther 16:110. https:\/\/doi.org\/10.1186\/s13195-024-01478-9","journal-title":"Alzheimers Res Ther"},{"key":"13556_CR11","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13195-021-00886-5","volume":"13","author":"HV Dansson","year":"2021","unstructured":"Dansson HV, Stempfle L, Egilsd\u00f3ttir H et al (2021) Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer\u2019s disease. Alzheimers Res Ther 13:151. https:\/\/doi.org\/10.1186\/s13195-021-00886-5","journal-title":"Alzheimers Res Ther"},{"key":"13556_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-019-0518-8","volume":"11","author":"LA Digma","year":"2019","unstructured":"Digma LA, Madsen JR, Reas ET et al (2019) Tau and atrophy: domain-specific relationships with cognition. Alzheimers Res Ther 11:65. https:\/\/doi.org\/10.1186\/s13195-019-0518-8","journal-title":"Alzheimers Res Ther"},{"key":"13556_CR13","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S1474-4422(20)30071-5","volume":"19","author":"TK Karikari","year":"2020","unstructured":"Karikari TK, Pascoal TA, Ashton NJ et al (2020) Blood phosphorylated tau 181 as a biomarker for Alzheimer\u2019s disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts. Lancet Neurol 19:422\u2013433. https:\/\/doi.org\/10.1016\/S1474-4422(20)30071-5","journal-title":"Lancet Neurol"},{"key":"13556_CR14","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1038\/s41591-021-01348-z","volume":"21","author":"S Palmqvist","year":"2022","unstructured":"Palmqvist S, Tideman P, Cullen N et al (2022) Prediction of future Alzheimer\u2019s disease dementia using plasma phospho-tau combined with other accessible measures. Lancet Neurol 21:1259\u20131272. https:\/\/doi.org\/10.1038\/s41591-021-01348-z","journal-title":"Lancet Neurol"},{"key":"13556_CR15","doi-asserted-by":"publisher","first-page":"E860","DOI":"10.1212\/WNL.0000000000201597","volume":"100","author":"J Sarto","year":"2023","unstructured":"Sarto J, Ruiz-Garc\u00eda R, Guill\u00e9n N et al (2023) Diagnostic performance and clinical applicability of blood-based biomarkers in a prospective memory clinic cohort. Neurology 100:E860\u2013E873. https:\/\/doi.org\/10.1212\/WNL.0000000000201597","journal-title":"Neurology"},{"issue":"8","key":"13556_CR16","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.jalz.2018.02.013","volume":"14","author":"MM Mielke","year":"2018","unstructured":"Mielke MM, Hagen CE, Xu J, Chai X, Vemuri P, Lowe VJ, Airey DC, Knopman DS, Roberts RO, Machulda MM, Jack CR Jr, Petersen RC, Dage JL (2018) Plasma phospho-tau181 increases with Alzheimer\u2019s disease clinical severity and is associated with tau- and amyloid-positron emission tomography. Alzheimers Dement 14(8):989\u2013997. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.013","journal-title":"Alzheimers Dement"},{"key":"13556_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40035-021-00234-5","volume":"10","author":"X Ding","year":"2021","unstructured":"Ding X, Zhang S, Jiang L et al (2021) Ultrasensitive assays for detection of plasma tau and phosphorylated tau 181 in Alzheimer\u2019s disease: a systematic review and meta-analysis. Transl Neurodegener 10:10. https:\/\/doi.org\/10.1186\/s40035-021-00234-5","journal-title":"Transl Neurodegener"},{"key":"13556_CR18","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/joim.12816","volume":"284","author":"K Blennow","year":"2018","unstructured":"Blennow K, Zetterberg H (2018) Biomarkers for Alzheimer\u2019s disease: current status and prospects for the future. J Intern Med 284:643\u2013663. https:\/\/doi.org\/10.1111\/joim.12816","journal-title":"J Intern Med"},{"key":"13556_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-018-0361-3","author":"RW Paterson","year":"2018","unstructured":"Paterson RW, Slattery CF, Poole T et al (2018) Cerebrospinal fluid in the differential diagnosis of Alzheimer\u2019s disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic. Alzheimers Res Ther. https:\/\/doi.org\/10.1186\/s13195-018-0361-3","journal-title":"Alzheimers Res Ther"},{"issue":"5","key":"13556_CR20","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1001\/jamaneurol.2016.6117","volume":"74","author":"N Mattsson","year":"2017","unstructured":"Mattsson N, Andreasson U, Zetterberg H et al (2017) Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease. JAMA Neurol 74(5):557\u2013566. https:\/\/doi.org\/10.1001\/jamaneurol.2016.6117","journal-title":"JAMA Neurol"},{"key":"13556_CR21","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1001\/jamaneurol.2021.3671","volume":"78","author":"AL Benedet","year":"2021","unstructured":"Benedet AL, Mil\u00e0-Alom\u00e0 M, Vrillon A et al (2021) Differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the Alzheimer disease continuum. JAMA Neurol 78:1471\u20131483. https:\/\/doi.org\/10.1001\/jamaneurol.2021.3671","journal-title":"JAMA Neurol"},{"issue":"8","key":"13556_CR22","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack Jr","year":"2024","unstructured":"Jack CR Jr, Andrews JS, Beach TG et al (2024) Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimers Dement 20(8):5143\u20135169. https:\/\/doi.org\/10.1002\/alz.13859","journal-title":"Alzheimers Dement"},{"issue":"3","key":"13556_CR23","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","volume":"7","author":"MS Albert","year":"2011","unstructured":"Albert MS, DeKosky ST, Dickson D et al (2011) The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging\u2013Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement 7(3):270\u2013279. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.008","journal-title":"Alzheimers Dement"},{"issue":"3","key":"13556_CR24","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H et al (2011) The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging\u2013Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement 7(3):263\u2013269. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.005","journal-title":"Alzheimers Dement"},{"issue":"3","key":"13556_CR25","first-page":"189","volume":"7","author":"A Lobo","year":"1979","unstructured":"Lobo A, Ezquerra J, G\u00f3mez Burgada F, Sala JM, Seva A (1979) El Mini-Examen Cognoscitivo (un test sencillo, pr\u00e1ctico, para detectar alteraciones intelectuales en pacientes m\u00e9dicos). Actas Luso Esp Neurol Psiquiatr Cienc Afines 7(3):189\u2013202","journal-title":"Actas Luso Esp Neurol Psiquiatr Cienc Afines"},{"key":"13556_CR26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/87565648709540361","volume":"3","author":"E Grober","year":"1987","unstructured":"Grober E, Buschke H (1987) Genuine memory deficits in dementia. Dev Neuropsychol 3:13\u201336. https:\/\/doi.org\/10.1080\/87565648709540361","journal-title":"Dev Neuropsychol"},{"key":"13556_CR27","first-page":"206","volume":"30","author":"PA Osterrieth","year":"1944","unstructured":"Osterrieth PA (1944) Le test de copie d\u2019une figure complexe: contribution \u00e0 l\u2019\u00e9tude de la perception et de la m\u00e9moire. Arch Psychol 30:206\u2013356","journal-title":"Arch Psychol"},{"issue":"9","key":"13556_CR28","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1212\/WNL.39.9.1159","volume":"39","author":"JC Morris","year":"1989","unstructured":"Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, Mellits ED, Clark C (1989) The consortium to establish a registry for Alzheimer\u2019s disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer\u2019s disease. Neurology 39(9):1159\u20131165. https:\/\/doi.org\/10.1212\/WNL.39.9.1159","journal-title":"Neurology"},{"key":"13556_CR29","volume-title":"Boston naming test","author":"E Kaplan","year":"2001","unstructured":"Kaplan E, Goodglass H, Weintraub S (2001) Boston naming test, 2nd edn. Lippincott Williams & Wilkins, Philadelphia","edition":"2"},{"key":"13556_CR30","unstructured":"Roth RM, Isquith PK, Gioia GA (2011) Category fluency test (CFT). In: Behavior rating inventory of executive function\u2013adult version (BRIEF-A). Psychological Assessment Resources, Lutz, FL"},{"key":"13556_CR31","volume-title":"The Boston diagnostic aphasia examination (BDAE)","author":"H Goodglass","year":"1983","unstructured":"Goodglass H, Kaplan E (1983) The Boston diagnostic aphasia examination (BDAE), 2nd edn. Lea & Febiger, Philadelphia","edition":"2"},{"key":"13556_CR32","doi-asserted-by":"crossref","unstructured":"Kertesz A (2007) Western Aphasia Battery (WAB), revised edition. Pearson Assessment, San Antonio, TX","DOI":"10.1037\/t15168-000"},{"issue":"3","key":"13556_CR33","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.nrl.2012.03.007","volume":"28","author":"L Calvo","year":"2013","unstructured":"Calvo L, Casals-Coll M, S\u00e1nchez-Benavides G, Quintana M, Manero RM, Rognoni T, Palomo R, Aranciva F, Tamayo F, Pe\u00f1a-Casanova J (2013) Spanish normative studies in young adults (NEURONORMA young adults project): norms for the visual object and space perception battery and judgment of line orientation tests. Neurolog\u00eda (Engl Ed) 28(3):153\u2013159. https:\/\/doi.org\/10.1016\/j.nrl.2012.03.007","journal-title":"Neurolog\u00eda (Engl Ed)"},{"key":"13556_CR34","unstructured":"Reitan RM (1994) Trail making test (TMT). Reitan Neuropsychology Laboratory, Tucson, AZ, USA"},{"key":"13556_CR35","volume-title":"Stroop color and word test: a manual for clinical and experimental uses","author":"CJ Golden","year":"1978","unstructured":"Golden CJ (1978) Stroop color and word test: a manual for clinical and experimental uses. Stoelting Co, Chicago, IL"},{"key":"13556_CR36","unstructured":"Smith A (1968) Symbol digit modalities test (SDMT). In: Learning disorders. Western Psychological Services, Los Angeles, pp 83\u201391"},{"key":"13556_CR37","unstructured":"Wechsler D (2012) Wechsler adult intelligence scale\u2014fourth edition (WAIS-IV). Pearson Assessment, San Antonio, TX"},{"key":"13556_CR38","doi-asserted-by":"crossref","unstructured":"Benton AL, Hamsher K deS, Sivan AB (1983) Controlled Oral Word Association Test (COWAT). In: Multilingual Aphasia Examination, 3rd edn. AJA Associates, Iowa City, IA","DOI":"10.1037\/t10132-000"},{"key":"13556_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s43587-025-00835-z","author":"R Ossenkoppele","year":"2025","unstructured":"Ossenkoppele R, Salvad\u00f3 G, Janelidze S et al (2025) Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trials. Nat Aging. https:\/\/doi.org\/10.1038\/s43587-025-00835-z","journal-title":"Nat Aging"},{"key":"13556_CR40","doi-asserted-by":"publisher","first-page":"7791","DOI":"10.1038\/s41598-025-90232-8","volume":"15","author":"HS Kwon","year":"2025","unstructured":"Kwon HS, Hwang M, Koh SH et al (2025) Comparison of plasma p-tau217 and p-tau181 in predicting amyloid positivity and prognosis among Korean memory clinic patients. Sci Rep 15:7791. https:\/\/doi.org\/10.1038\/s41598-025-90232-8","journal-title":"Sci Rep"},{"issue":"1","key":"13556_CR41","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000213769","volume":"105","author":"J Selma-Gonzalez","year":"2025","unstructured":"Selma-Gonzalez J, Rubio-Guerra S, Garc\u00eda-Castro J, Vera-Campuzano E, Sala I, S\u00e1nchez-Saudin\u00f3s MB, Zhu N, Arranz J, Arriola-Infante JE, Rodr\u00edguez-Baz \u00cd, Maure-Blesa L, Dols-Icardo O, Videla L, Valldeneu S, Barroeta I, Santos-Santos M, Carmona-Iragui M, Vaqu\u00e9-Alc\u00e1zar L, Alvarez-Sanchez E, Lorente O, Carreras M, Belbin O, Arslan B, Ashton NJ, Zetterberg H, Blennow K, Montoliu-Gaya L, Bejanin A, Lle\u00f3 A, Fortea J, Alcolea D, Illan-Gala I (2025) Association of plasma phosphorylated tau 217 with clinical deterioration across Alzheimer disease stages. Neurology 105(1):e213769. https:\/\/doi.org\/10.1212\/WNL.0000000000213769","journal-title":"Neurology"},{"key":"13556_CR42","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1093\/brain\/awac333","volume":"146","author":"S Janelidze","year":"2023","unstructured":"Janelidze S, Bali D, Ashton NJ et al (2023) Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer\u2019s disease. Brain 146:1592\u20131601. https:\/\/doi.org\/10.1093\/brain\/awac333","journal-title":"Brain"},{"issue":"3","key":"13556_CR43","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1007\/s00415-023-12066-6","volume":"271","author":"A Vrillon","year":"2024","unstructured":"Vrillon A, Ashton NJ, Karikari TK, G\u00f6tze K, Cognat E, Dumurgier J, Lilamand M, Zetterberg H, Blennow K, Paquet C (2024) Comparison of CSF and plasma NfL and pNfH for Alzheimer\u2019s disease diagnosis: a memory clinic study. J Neurol 271(3):1297\u20131310. https:\/\/doi.org\/10.1007\/s00415-023-12066-6","journal-title":"J Neurol"},{"issue":"12","key":"13556_CR44","doi-asserted-by":"publisher","first-page":"4094","DOI":"10.1093\/brain\/awae211","volume":"147","author":"DE Peretti","year":"2024","unstructured":"Peretti DE, Boccalini C, Ribaldi F, Scheffler M, Marizzoni M, Ashton NJ, Zetterberg H, Blennow K, Frisoni GB, Garibotto V (2024) Association of glial fibrillary acid protein, Alzheimer\u2019s disease pathology and cognitive decline. Brain 147(12):4094\u20134104. https:\/\/doi.org\/10.1093\/brain\/awae211","journal-title":"Brain"},{"key":"13556_CR45","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/alz.13450","volume":"20","author":"W Pelkmans","year":"2024","unstructured":"Pelkmans W, Shekari M, Brugulat-Serrat A et al (2024) Astrocyte biomarkers GFAP and YKL-40 mediate early Alzheimer\u2019s disease progression. Alzheimers Dement 20:483\u2013493. https:\/\/doi.org\/10.1002\/alz.13450","journal-title":"Alzheimers Dement"},{"key":"13556_CR46","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1093\/brain\/awab223","volume":"144","author":"JB Pereira","year":"2021","unstructured":"Pereira JB, Janelidze S, Smith R et al (2021) Plasma GFAP is an early marker of amyloid-\u03b2 but not tau pathology in Alzheimer\u2019s disease. Brain 144:3505\u20133516. https:\/\/doi.org\/10.1093\/brain\/awab223","journal-title":"Brain"},{"key":"13556_CR47","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1038\/s41591-021-01456-w","volume":"27","author":"TA Pascoal","year":"2021","unstructured":"Pascoal TA, Benedet AL, Ashton NJ et al (2021) Microglial activation and tau propagate jointly across Braak stages. Nat Med 27:1592\u20131599. https:\/\/doi.org\/10.1038\/s41591-021-01456-w","journal-title":"Nat Med"},{"key":"13556_CR48","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1083\/jcb.201709069","volume":"217","author":"DV Hansen","year":"2018","unstructured":"Hansen DV, Hanson JE, Sheng M (2018) Microglia in Alzheimer\u2019s disease. J Cell Biol 217:459\u2013472. https:\/\/doi.org\/10.1083\/jcb.201709069","journal-title":"J Cell Biol"},{"key":"13556_CR49","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s00259-015-3047-0","volume":"42","author":"E Rodriguez-Vieitez","year":"2015","unstructured":"Rodriguez-Vieitez E, Ni R, Guly\u00e1s B et al (2015) Astrocytosis precedes amyloid plaque deposition in Alzheimer APPswe transgenic mouse brain: a correlative positron emission tomography and in vitro imaging study. Eur J Nucl Med Mol Imaging 42:1119\u20131132. https:\/\/doi.org\/10.1007\/s00259-015-3047-0","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"13556_CR50","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1002\/alz.12283","volume":"17","author":"J Simr\u00e9n","year":"2021","unstructured":"Simr\u00e9n J, Leuzy A, Karikari TK et al (2021) The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer\u2019s disease. Alzheimers Dement 17:1145\u20131156. https:\/\/doi.org\/10.1002\/alz.12283","journal-title":"Alzheimers Dement"},{"key":"13556_CR51","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s13195-020-00710-6","volume":"12","author":"MS Baek","year":"2020","unstructured":"Baek MS, Cho H, Lee HS et al (2020) Effect of APOE \u03b54 genotype on amyloid-\u03b2 and tau accumulation in Alzheimer\u2019s disease. Alzheimers Res Ther 12:140. https:\/\/doi.org\/10.1186\/s13195-020-00710-6","journal-title":"Alzheimers Res Ther"},{"key":"13556_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-023-01277-8","author":"H Stocker","year":"2023","unstructured":"Stocker H, Trares K, Beyer L et al (2023) Alzheimer\u2019s polygenic risk scores, APOE, Alzheimer\u2019s disease risk, and dementia-related blood biomarker levels in a population-based cohort study followed over 17 years. Alzheimers Res Ther. https:\/\/doi.org\/10.1186\/s13195-023-01277-8","journal-title":"Alzheimers Res Ther"},{"key":"13556_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1119070","author":"L Shang","year":"2023","unstructured":"Shang L, Dong L, Huang X et al (2023) Association of APOE \u03b54\/\u03b54 with fluid biomarkers in patients from the PUMCH dementia cohort. Front Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2023.1119070","journal-title":"Front Aging Neurosci"},{"key":"13556_CR54","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41398-021-01476-7","volume":"11","author":"SD Chen","year":"2021","unstructured":"Chen SD, Huang YY, Shen XN et al (2021) Longitudinal plasma phosphorylated tau 181 tracks disease progression in Alzheimer\u2019s disease. Transl Psychiatry 11:356. https:\/\/doi.org\/10.1038\/s41398-021-01476-7","journal-title":"Transl Psychiatry"},{"key":"13556_CR55","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/s43587-023-00403-3","volume":"3","author":"O Hansson","year":"2023","unstructured":"Hansson O, Blennow K, Zetterberg H et al (2023) Blood biomarkers for Alzheimer\u2019s disease in clinical practice and trials. Nat Aging 3:506\u2013519. https:\/\/doi.org\/10.1038\/s43587-023-00403-3","journal-title":"Nat Aging"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13556-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13556-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13556-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T12:58:30Z","timestamp":1773665910000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13556-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["13556"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13556-5","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,17]]},"assertion":[{"value":"9 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki (Fortaleza, 2013) and applicable Spanish regulations governing research with human subjects. The Hospital Cl\u00ednic de Barcelona Ethics Committee approved the study (HCB\/2019\/0203).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All the participants signed the informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"28"}}